Search

Search Constraints

You searched for: Author/Creator Tormo, M.

Search Results

1. 244 MYELOFIBROSIS (MF) AS A PROGNOSTIC TOOL FOR OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE EVALUATION INCLUDING MUTATIONAL ANALYSIS BY NEXT GENERATION SEQUENCING (NGS). Issue 1 (April 2015)

2. 260 CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS. Issue 1 (April 2015)

4. 90 INTENSIVE CHEMOTHERAPY VERSUS NO INTENSIVE TREATMENT IN HIGH RISK MYELODYSPLASTYC SYNDROME (MDS) NO-HSCT CANDIDATES. (April 2015)

5. Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance. (April 2017)

6. Clinical and Biological Significance of Y Chromosome Loss in a Series of 2, 423 Male Patients with MDS and CMML. (April 2017)

7. Impact of anaemia on health‐related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL study. (4th January 2016)

8. Impact of DNMT3A and IDH1/IDH2 Mutations on Treatment Response with Azacitidine in Myeloid Neoplasms. (April 2017)

9. P1702: IMPACT OF CENTER CHARACTERISTICS AND MACROECONOMIC FACTORS ON THE OUTCOME OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC-INSPIRED PROTOCOLS. (23rd June 2022)

10. P385: DETECTION OF KMT2A PARTIAL TANDEM DUPLICATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS BY NGS. (23rd June 2022)